Demand for colour images, digitisation initiatives and enhanced image quality will boost the market for medical displays in Europe. However, the high cost of certain displays will act as a deterrent to adoption.
New analysis from Frost & Sullivan (medicalimaging.frost.com), European Medical Displays Markets, finds that the markets earned revenues of $268.6 million in 2010 and estimates this to reach $507.4 million in 2015. The market is expected to grow at a compound annual growth rate (CAGR) of 13.6 per cent from 2008 to 2012. The following segments are covered in the research: clinical, surgical, picture archiving and communication (PACS), acquisition and mammography displays.
"Key drivers for this growth include use of displays in the cardiology PACS sector and increasing demand for displays with better image quality and features such as contrast and luminance," notes Frost & Sullivan Industry Analyst Dr. Gideon Praveen Kumar. "Another driver is anticipated to be the increased adoption of clinical review displays, which accounted for a share of about 42 per cent of the total units shipped in 2010."
Market expansion is likely to be augmented by the growing sales of mammography displays. Sales of surgical display monitors are also projected to rise in the future. However, increased sales are likely to be achieved through a decrease in the average selling prices of such display units.
Since late 2006, there has been a surge in demand for colour images in medical equipment displays. This has led to the need for hybrid workstations with more advanced functionalities than conventional PACS ones.
"This requires the medical displays to render colour images of high contrast as well as brightness and the related software to possess post-processing capabilities to allow 3D imaging," explains Dr. Kumar. "The mounting demand for such high-quality, colour images is set to sustain market expansion."
Digitisation initiatives are also supporting market prospects. The rising uptake of digital units is driving the volume sales of display monitors. Dental pathology represents another area where digitisation is occurring.
The market for medical imaging displays is currently experiencing a shift. The increasing popularity of digitisation initiatives over Europe is trailing the integral components of the digital set-up in its wake.
The focus on enhanced image quality is also fuelling market growth. Image quality plays a crucial role in the choice of medical displays. The escalating demand for image quality is motivating medical display manufacturers to keep their products up-to-date.
"Radiologists depend on the quality of contrast being provided, as it has a direct impact on their confidence in terms of what they can read from the displays," remarks Dr.Kumar. "Radiologists look for an optimal combination of brighter screens and good ratio of the luminance."
Unfortunately, with limited budgets, most hospitals in Europe have been hesitant about investing in surgical displays for operating rooms and emergency rooms. This has affected the sale of high definition (HD) liquid crystal display (LCD) monitors and their use in minimally invasive procedures, such as laparoscopy and endoscopy.
Strategies for success include the introduction of competitive pricing or the use of innovative offers to promote product sales. The establishment of efficient distribution channels offers another route to maintain market momentum.
"Market participants can also form strategic partnerships with global vendors and target the booming private sector to achieve enhanced market penetration," concludes Kumar.
If you are interested in more information on this study, please send an email with your contact details to Janique Morvan, Corporate Communications, at janique.morvan[.]frost.com.
European Medical Displays Markets is part of the Medical Imaging Growth Partnership Service programme, which also includes research in the following markets: Future Outlook for Common IT Platforms – Radiology and Cardiology, RIS/PACS Market, Cardiology Information Systems Market and European Cardiology PACS Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.
European Medical Displays Markets / M6B9